Neurology 1601 - Neurology Alert - Jan 01, 2012

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology and Neuroscience

Assistant Editors
Michael Rubin, MD, FRCP(C)
Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders

Alan Z. Segal, MD
Associate Professor of Clinical Neurology
Weill Cornell Medical College

Dara G. Jamieson, MD
Associate Professor of Clinical Neurology;
Specialty area, Headache

Authors

Halinder S. Mangat, MD
Assistant Professor of Clinical Neurology
Weill Cornell Medical College

Marc Dinkin, MD
Assistant Professor of Ophthalmology
Weill Cornell Medical College

Subjects:

  • Spreading Depolarisations After TBI: A Clinical Context
  • Brain Involvement in Neuromyelitis Optica — An Evolving Concept
  • Plasma Exchange for Steroid-Unresponsive Optic Neuritis
  • Predicting Outcome after Epidural Steroid Injection
  • A New Look at an Old Medication for Migraine Headaches — Is It Worth It?
  • Stroke Alert: A Review of Current Clinical Stroke Literature

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's editor in chief, Matthew Fink, MD, is a retained consultant for MAQUET. Assistant editors Michael Rubin, MD, FRCP(C), Dara G. Jamieson, MD, Alan Z. Segal, MD, authors Halinder S. Mangat, MD, Marc Dinkin, MD, and peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study. Author Jai S. Perumal, MD is a consultant for Biogen Idec, and is on the speakers bureau for Teva and Biogen Idec.

Copyright 2012 AHC Media LLC. All rights reserved.